GGrantIndex
← Search

NEURO-IMMUNO MODULATING ANALGESIC (NIMA) NANOMEDICINE PLATFORM FOR TREATMENT OF DIABETIC NEUROPATHY

$1,187,157FY2020Defense Health AgencyDOD

Duquesne University Of The Holy Spirit

Investigators

View source on USAspending →
NEURO-IMMUNO MODULATING ANALGESIC (NIMA) NANOMEDICINE PLATFORM FOR TREATMENT OF DIABETIC NEUROPATHY · GrantIndex